Characterization of Endoderm Stem Cells Derived from Murine ESCs
鼠 ESC 来源的内胚层干细胞的表征
基本信息
- 批准号:7658494
- 负责人:
- 金额:$ 18.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-22 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlveolar CellAnimalsBackBeta CellCell Adhesion MoleculesCell LineCell SeparationCellsCharacteristicsCoculture TechniquesCommitCultured CellsDataDerivation procedureDevelopmentES Cell LineEmbryoEndodermEndoderm CellEnvironmentEpithelial CellsEpitheliumGenerationsGenesGerm LayersGlucoseGoalsGrowthGrowth FactorHepatocyteHumanImmunodeficient MouseIn VitroInjection of therapeutic agentInsulinIslets of LangerhansKnowledgeLengthLiverLungMagnetismMorphologyMusNoduleOrganOrgan DonorPancreasPatternPhenotypePopulationPopulation HeterogeneityPrimitive StreaksPrimitive foregut structureProductionProtocols documentationPublishingReplacement TherapySignal TransductionSorting - Cell MovementSourceStem cell transplantStem cellsStructure of beta Cell of isletTeratomaTestingTherapeuticTimeTissuesTo specifyTransplantationUndifferentiatedVisceralbaseblastomere structurecell typeembryonic stem cellimprovedin vivopancreas developmentpublic health relevancesegregationstem cell populationtumorigenic
项目摘要
DESCRIPTION (provided by applicant): Embryonic stem cells (ESCs) are envisioned as a source of transplantable pancreatic islets to alleviate the donor organ shortage. Despite many recent advances, protocols to differentiate ESCs to homogeneous pools of glucose-responsive insulin-secreting beta cells have yet to be developed. It is widely accepted that the production of these populations will first require generation of definitive endoderm. Thus, the successful derivation and stable propagation of endoderm-restricted stem cell lines would be a significant step forward in the development of pancreas, liver, and lung cells for cell replacement therapies and for improving our understanding of how these tissues are normally formed from this germ layer. We have developed a simple protocol, using magnetic-activated cell sorting (MACS), to isolate endoderm-committed cells from heterogeneous cultures of differentiated murine ESCs on the basis of epithelial cell adhesion molecule (EpCAM) expression. The protocol includes negative selection to remove undifferentiated ESCs and visceral endoderm cells, and positive selection to retain cells that express EpCAM. When sorted cells are placed sub-cutaneously into immunodeficient mice, small EpCAM+PDX1+ nodules highly reminiscent of embryonic pancreatic epithelium develop. Cells from these nodules can be extensively propagated in vitro and have the characteristics expected of an endodermal stem cell (EndSC) or foregut- restricted stem cell (FGSC) population, depending on the duration of growth in vivo. The EndSCs are OCT4+ and express some early endoderm-restricted genes, whereas FGSCs are OCT4- and have high expression of Sox17, Foxa2, and PDX1. EndSCs and FGSCs transplanted back into animals recapitulate the original nodule phenotype, demonstrating their stability in vitro. We hypothesize that only the OCT4+EpCAM+SSEA1- cells recovered from the MACS separation give rise to the in vivo-derived endodermal cell lines. Here, we will directly test this hypothesis by FACS-sorting OCT4+EpCAM+SSEA1- cells using an OCT4GFP ESC line. Cell lines derived from the FACS-sorted population will be compared to the existing MACS-derived EndSCs and FGSCs. We will also study the ability of EndSCs and FGSCs to differentiate in vitro to specific endoderm-derived cell types, including beta cells. To promote differentiation, we will culture cells in an embryonic pancreas environment, expose cells to relevant growth factor signals, and culture cells according to recently published protocols. These studies will contribute not only to improved differentiation efficiency of ESCs to definitive endoderm and pancreatic lineages, but also to a better understanding of germ layer segregation and early embryonic cell fate decisions. PUBLIC HEALTH RELEVANCE: Our preliminary studies have led to the development of cell lines from differentiated mouse embryonic stem cells (ESCs) that appear to be foregut endoderm-committed. These cell lines are non-tumorigenic and grow well in culture, and here we propose to elucidate the cell of origin of these endodermal cell lines and explore their ability to differentiate into pancreatic, liver, and lung cells in vitro. This knowledge will help in establishing protocols for the isolation and differentiation of human endoderm-committed cells for the production of functional cells to be used in transplantation therapies.
描述(由申请人提供):胚胎干细胞(ESC)被设想为可移植胰岛的来源,以减轻供体器官短缺。尽管最近取得了许多进展,但尚未开发出葡萄糖反应性胰岛素β细胞的ESC与均质池库的协议。人们普遍认为,这些人群的生产将首先需要生成确定的内胚层。因此,在胰腺,肝脏和肺细胞的发展中,成功的衍生和稳定传播将是向细胞替代疗法的发展,以及提高我们对这些组织通常如何从该生殖层形成这些组织的理解,这将是向前迈出的重要一步。我们使用磁性细胞分选(MAC)开发了一个简单的方案,以根据上皮细胞粘附分子(EPCAM)表达分离内胚层的细胞从分化的鼠ESC的异质培养物中分离出来。该方案包括负面选择以去除未分化的ESC和内脏内胚层细胞,以及阳性选择以保留表达EPCAM的细胞。当分类的细胞置于免疫缺陷的小鼠中时,小的EPCAM+ PDX1+结节高度让人联想到胚胎胰腺上皮发展。这些结节的细胞可以在体外广泛传播,并具有内胚层干细胞(ENDSC)或前述限制的干细胞(FGSC)群体的特征,具体取决于体内生长持续时间。 EndScs为Oct4+,表达一些早期的内胚层限制基因,而FGSC为OCT4-,并且具有SOX17,FOXA2和PDX1的高表达。 EndScs和FGSC被移植到动物中,概括了原始的结节表型,表明它们在体外的稳定性。我们假设只有从MAC分离中回收的OCT4+EPCAM+SSEA1-细胞会产生体内衍生的内胚层细胞系。在这里,我们将使用OCT4GFP ESC线直接通过对OCT4+EPCAM+SSEA1-细胞进行FACS进行faceS分类来直接检验该假设。将源自FACS的人群得出的细胞系将与现有的MAC衍生的ENDSC和FGSC进行比较。我们还将研究EndSC和FGSC在体外区分特定内胚层细胞类型(包括β细胞)的能力。为了促进分化,我们将根据最近发表的方案在胚胎胰腺环境中培养细胞,使细胞暴露于相关的生长因子信号和培养细胞。这些研究不仅将有助于提高ESC对确定的内胚层和胰腺谱系的分化效率,而且还有助于更好地理解生殖层分离和早期的胚胎细胞命运决策。公共卫生相关性:我们的初步研究导致了来自分化小鼠胚胎干细胞(ESC)的细胞系的发展,这些细胞(ESC)似乎是腹部内胚层的。这些细胞系是非肿瘤的,在培养中生长良好,在这里我们建议阐明这些内胚层细胞系的起源细胞,并探索它们分化为体外胰腺,肝脏和肺细胞的能力。这些知识将有助于建立隔离和分化人内毒性细胞的方案,以生产用于移植疗法的功能细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jon S Odorico其他文献
Reduced Intensity Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorders (PTLD) Is Associated with Preserved Survival Outcomes: A Twenty-Year Single-Institutional Experience
- DOI:
10.1182/blood-2024-193519 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Bradley Shogo Uyemura;Zhanhai Li;David T Yang;Michael Fallon;Jon S Odorico;Julie E Chang - 通讯作者:
Julie E Chang
Jon S Odorico的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jon S Odorico', 18)}}的其他基金
Transformational platform for regenerating autologous transplantable endocrine tissue from human pancreatic matrix and pluripotent stem cells
从人胰腺基质和多能干细胞再生自体可移植内分泌组织的转化平台
- 批准号:
9169474 - 财政年份:2016
- 资助金额:
$ 18.56万 - 项目类别:
Transformational platform for regenerating autologous transplantable endocrine tissue from human pancreatic matrix and pluripotent stem cells
从人胰腺基质和多能干细胞再生自体可移植内分泌组织的转化平台
- 批准号:
9307694 - 财政年份:2016
- 资助金额:
$ 18.56万 - 项目类别:
ISLET TRANSPLANTATION IN TYPE 1 DIABETES USING STEROID-FREE IMMUNOSUPPRESSION
使用无类固醇免疫抑制的 1 型糖尿病胰岛移植
- 批准号:
7204338 - 财政年份:2005
- 资助金额:
$ 18.56万 - 项目类别:
PANCREATIC ISLET DIFFERENTIATION FROM RHESUS ES CELLS AND TRANSPLANTATION
恒河猴 ES 细胞的胰岛分化及移植
- 批准号:
7165675 - 财政年份:2005
- 资助金额:
$ 18.56万 - 项目类别:
PANCREATIC ISLET DIFFERENTIATION FROM RHESUS ES CELLS
来自恒河猴 ES 细胞的胰岛分化
- 批准号:
6971232 - 财政年份:2004
- 资助金额:
$ 18.56万 - 项目类别:
Islet Transplantation in Type 1 Diabetes Using Steroid-Free Immunosuppression
使用无类固醇免疫抑制进行 1 型糖尿病胰岛移植
- 批准号:
7043884 - 财政年份:2003
- 资助金额:
$ 18.56万 - 项目类别:
RHESUS ES CELLS: A MODEL TO STUDY PANCREAS DEVELOPMENT
恒河猴 ES 细胞:研究胰腺发育的模型
- 批准号:
6089128 - 财政年份:2000
- 资助金额:
$ 18.56万 - 项目类别:
RHESUS ES CELLS: A MODEL TO STUDY PANCREAS DEVELOPMENT
恒河猴 ES 细胞:研究胰腺发育的模型
- 批准号:
6381948 - 财政年份:2000
- 资助金额:
$ 18.56万 - 项目类别:
相似国自然基金
DsbA-L促进肺泡上皮细胞铁死亡加重脓毒症肺损伤的机制研究
- 批准号:82360377
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Birc6泛素化调控Beclin-1在肺纤维化肺泡上皮细胞衰老中的功能及机制研究
- 批准号:82300093
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
丙酮酸羧化酶乳酸化修饰介导TCA回补途径调控肺泡巨噬细胞极化在脓毒症ARDS中的机制研究
- 批准号:82300100
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
骨肉瘤细胞通过分泌蛋白SMOC1诱导肺泡巨噬细胞极化促进其肺转移的作用及其机制
- 批准号:82373026
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Ⅱ型肺泡上皮细胞RIPK3经调节SLIT3/ROBO2轴促进成纤维细胞增殖在肺纤维化中的作用与机制研究
- 批准号:82300097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Assessing the role of Type I Interferon (IFN-I) in Periodontal Disease
评估 I 型干扰素 (IFN-I) 在牙周病中的作用
- 批准号:
10558868 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Personalized bioprinting technology for de novo PDL regeneration
用于 PDL 从头再生的个性化生物打印技术
- 批准号:
10667088 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Mechanisms of oxygen off-loading from red blood cells in murine models of human disease
人类疾病小鼠模型中红细胞的氧卸载机制
- 批准号:
10343967 - 财政年份:2022
- 资助金额:
$ 18.56万 - 项目类别: